Or. Admin. Code § 836-200-0520

Current through Register Vol. 64, No. 1, January 1, 2025

Section 836-200-0520 - Threshold for Reporting New Specialty Drug

Beginning March 15, 2019, 30 days or less after a manufacturer introduces a new prescription drug for sale in the United States at a price for a 30 day supply or for a course of treatment lasting less than one month that exceeds the threshold established by the Centers for Medicare and Medicaid Services for specialty drugs in the Medicare Part D program, the manufacturer must report to the department the information described in OAR 836-200-0530(4).

ID 2-2019, adopt filed 02/26/2019, effective 3/1/2019

Statutory/Other Authority: 2018 Or Laws ch 7

Statutes/Other Implemented: 2018 Or Laws ch 7